Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs 2023-11-07 21:30
Kexing Biopharm Attended CPHI Worldwide 2023 2023-11-07 20:09
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) 2023-11-07 20:00
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate 2023-11-07 14:14
87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting 2023-11-07 12:31
KN026 was Granted Breakthrough Therapy Designation by CDE 2023-11-07 08:51
Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia 2023-11-07 08:15
Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia 2023-11-07 08:15
Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia 2023-11-07 08:15
Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia 2023-11-07 08:15
Lerna Bio unveils its first-in-class solution to combat liver failure 2023-11-06 22:00
I-Mab Announces Participation at Jefferies and Piper Conferences in November 2023-11-06 21:00
Phase I Study Results for Qilu Pharmaceutical's Iparomlimab (QL1604) Now Published 2023-11-06 18:54
'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum 2023-11-06 17:07
Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D 2023-11-06 12:20
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval 2023-11-06 09:11
Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023 2023-11-06 08:00
Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy 2023-11-05 08:00
Verismo Therapeutics Announces Upcoming Presentation at SITC 2023 2023-11-03 21:00
The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan 2023-11-03 12:10
1 69 70 71 72 73 413